BridgeBio is significantly advanced this development of an new therapy for ATTR-CM, leveraging Attruby. Early clinical data indicates significant benefits for individuals affected by the severe illness. This emphasis https://attruby079218.arwebo.com/64714581/bridgebio-progresses-amyloidosis-therapy-using-the-drug